Observational Research, Senior Manager; Obesity

Join Amgen’s Mission of Serving Patients

At Amgen, if you feel like you’re part of something bigger, it’s because you are. Our shared mission—to serve patients living with serious illnesses—drives all that we do.

Since 1980, we’ve helped pioneer the world of biotech in our fight against the world’s toughest diseases. With our focus on four therapeutic areas –Oncology, Inflammation, General Medicine, and Rare Disease– we reach millions of patients each year. As a member of the Amgen team, you’ll help make a lasting impact on the lives of patients as we research, manufacture, and deliver innovative medicines to help people live longer, fuller happier lives.

Our award-winning culture is collaborative, innovative, and science based. If you have a passion for challenges and the opportunities that lay within them, you’ll thrive as part of the Amgen team. Join us and transform the lives of patients while transforming your career.

Observational Research, Senior Manager (Obesity)

Let’s do this. Let’s change the world. Do you like to work within scientific and commercial teams to generate real-world evidence (RWE); RWE that supports an ever-changing landscape of unique and evolving business needs? If so, we invite you to explore Amgen’s Center for Observational Research (CfOR).

Here in CfOR we are a team of scientists. We conduct observational research across the drug development and commercialization lifecycle. The data we produce informs clinical trial design, supports regulatory decision making and aids in the commercialization of our products. Study designs range from evaluating disease frequencies and current standards of care to understanding the safety and effectiveness of our medicines.

We partner with internal and external teams to produce the highest quality RWE to enable rapid decision making. The goal of everything we do is to contribute to the development of the best possible medicines and bring these medicines to patients as quickly as possible.

Your role as an Observational Research Senior Manager will be to lead projects and teams in support of that mission: to serve patients. You will be gathering insights and building collaborations and capabilities to advance the generation, use, and dissemination of RWE. This position will support the obesity therapeutic area and require you to be an effective communicator, critical thinker, and adept scientist.

We are in an exciting time in with a constantly shifting disease landscape. Your ability to execute on the science and deliver results efficiently and effectively will be the key to your success.

• Develop study proposals using real-world data to address key business questions as identified within the cross-functional teams. For example, identifying an appropriate database and collaborator to evaluate disease severity in a particular patient population.
• Lead the design, completion, and delivery of RWE. For example, build a study to evaluate the safety and effectiveness of an Amgen medicine to inform a regulatory decision (e.g., label expansion/change) and fulfill a global or regional regulatory requirement.
• Facilitate the dissemination of RWE through key presentations, publications and/or trainings. For example, develop a scientifically based promotional resource targeting a broad spectrum of external partners (e.g., health care providers, payers, integrated delivery networks).
• Collaborate on the development of an integrated evidence generation plan for the product team. This would require discussion and alignment on the conceptualization and design of real-world data studies focused on the strategies and priorities of your cross-functional partners.
• Contribute to the development and implementation of innovative analytic methods. For example, leverage CfOR’s internal data and analytics center to complete a study evaluating the comparative effectiveness of an Amgen medicine vs. an appropriate comparator.
• Partner with cross-functional colleagues to enhance the use of RWE. For example, develop a substitute for and/or a complement to an interventional study to reduce the time and cost of a particular drug development goal.
• Bu…